Automated Image Analysis in the Evaluation of Facial Pigmentation in Melasma: Clinical Application of Pycnogenol
Journal of Cosmetic Dermatology · 2026-11 · 25 (11)
DOI: 10.1111/jocd.71274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 05.11.2026. Verfasst von Sullege Fabiola Suzuki und 2 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Melasma is characterized by chronic hyperpigmentation and has a significant psychosocial impact. Traditional clinical assessments are limited due to subjectivity and low sensitivity to detect small changes.
Objective
To evaluate the progression of facial pigmentation in patients undergoing melasma treatment over 60 days using automated image processing based on artificial intelligence.
Methods
This prospective clinical trial enrolled 30 individuals with facial melasma into intervention (Pycnogenol 75 mg/day) and control group. Standardized photographs were obtained at baseline (T 0 ), 30 days (T 30 ), and 60 days (T 60 ). Images were processed using a computational pipeline that included automatic renaming, facial segmentation with MediaPipe, extraction of the mean intensity across RGB channels, and application of principal component analysis. Linear mixed‐effects models assessed the effects of group, time, and group‐by‐time interaction.
Results
PC1 accounted for 99.35% of the variance in gray intensity, indicating a robust marker of pigmentation. A significant effect of time was observed ( p = 0.048), indicating overall changes in pigmentation over the 60‐day period, with greater changes during the first 30 days. Group‐by‐time interaction showed p = 0.056, suggesting a trend toward greater response in the intervention group. This group was also marked by reduced PC1 at T 30 , followed by stabilization at T 60 .
Conclusion
The automated analysis of facial images proved to be an objective tool for monitoring melasma and detecting subtle changes not captured by subjective clinical methods. Treatment with Pycnogenol showed greater lightening than placebo, particularly during the first month.
Zitieren
APA
Suzuki, S. F., Musis, C. R. D., & Shimoya‐Bittencourt, W. (2026). Automated Image Analysis in the Evaluation of Facial Pigmentation in Melasma: Clinical Application of Pycnogenol. Journal of Cosmetic Dermatology, 25(11). https://doi.org/10.1111/jocd.71274
Vancouver
Suzuki SF, Musis CRD, Shimoya‐Bittencourt W. Automated Image Analysis in the Evaluation of Facial Pigmentation in Melasma: Clinical Application of Pycnogenol. Journal of Cosmetic Dermatology. 2026;25(11). doi:10.1111/jocd.71274
BibTeX
@article{Suzuki2026,
author = {Suzuki, Sullege Fabiola and Musis, Carlo Ralph de and Shimoya‐Bittencourt, Walkiria},
title = {Automated Image Analysis in the Evaluation of Facial Pigmentation in Melasma: Clinical Application of Pycnogenol},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
volume = {25},
number = {11},
doi = {10.1111/jocd.71274}
}
EUVIMED